Reference Distributions for Complement Proteins C3 and C4: A Comparison of a Large Cohort to the World's Literature

Journal of Clinical Laboratory Analysis

Volumn 18, Issue 1, 2004, Pages 9-13

  Ritchie, Robert F ^a   Palomaki, Glenn E ^a   Neveux, Louis M ^a   Navolotskaia, Olga ^a  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

Acute phase proteins; C3; C4; Caucasian; Complement; CRM 470 RPPHS; Meta analysis; Reference range; Serum proteins

Indexed keywords

ACUTE PHASE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; PLASMA PROTEIN;

ACUTE PHASE RESPONSE; ARTICLE; CAUCASIAN; CHOLESTASIS; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; HUMAN; META ANALYSIS; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; REFERENCE VALUE; RELIABILITY; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION;

CHEMISTRY, CLINICAL; COHORT STUDIES; COMPLEMENT C3; COMPLEMENT C4; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; REFERENCE VALUES;

EID: 0842282487     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.10095     Document Type: Article

References (63)

1. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature. J Clin Lab Anal 1998;12:371-377.
2. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for the negative acute phase proteins, albumin, transferrin and transthyretin: a comparison of a large cohort to the world's literature. J Clin Lab Anal 1999;13:280-286.
3. 1-antitrypsin and haptoglobin: a comparison of a large cohort to the world's literature. J Clin Lab Anal 2000;14:265-270.
4. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for serum iron, total iron binding capacity and transferrin saturation: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2002;16:237-245.
5. Whicher JT, Ritchie RF, Johnson AM, Baudner S, Bienvenu J, Blirup-Jensen S. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934-938.
6. Lewis EJ, Carpenter CB, Schur PH. Serum complement levels in human glomerulonephritis. Ann Intern Med 1971;75:555-560.
7. Higashi GI, Chowdhury AB. Immunoglobulins and complement in sera from patients with various parasitic infections. Ind J Med Res 1971;59:382-389.
8. Weeke B, Krasilnikoff PA. The concentration of 21 serum proteins in normal children and adults. Acta Med Scand 1972;192:149-155.
9. Norman ME, Gall EP, Taylor A, Laster L, Nilsson UR, Serum complement profiles in infants and children. J Pediatr 1975;87:912-916.
10. Ruddy S, Carpenter CB, Chin KW, et al. Human complement metabolism: an analysis of 144 studies. Medicine 1975;54:165-178.
11. Svartman M, Potter EV, Poon-King T, Earle DP. Immunoglobulins and complement component in synovial fluid of patients with acute rheumatic fever. J Clin Invest 1975;56:111-117.
12. Statland BE, Winkel P, Killingsworth LM. Factors contributing to intra-individual day-to-day variation in concentrations of 10 specific proteins in sera of healthy subjects. Clin Chem 1976;22:1635-1638.
13. Butts WC, James GE, Keuhneman M. Intra-individual variation in the concentrations of IgA, IgG, IgM, and compliment component C3 in serum of a normal adult population. Clin Chem 1977;23:511-514.
14. Buffone GJ, Lewis SA. Effect of analytical factors on immunochemical reference limits for complement component C3 in serum of a reference pediatric population. Clin Chem 1977;23:994-999.
15. Adamkin D, Stitzel A, Urmson J, Farnett ML, Post E, Spitzer R. Activity of the alternative pathway of complement in the newborn infants. J Pediatr 1978;93:604-608.
16. Strunk RC, Fenton LJ, Gaines JA. Alternative pathway of complement activation in full term and premature infants. Pediatr Res 1979;13:641-643.
17. Davis CA, Vallota EH, Forristal J. Serum complement levels in infancy: age related changes. Pediatr Res 1979;13:1043-1046.
18. Ritchie RF. Serum protein profile analysis and interpretation: some basic information. In: Nakamura RM, Dito WR, Tucker ES III, eds. Immunoassays in the clinical laboratory. New York: Alan R. Liss; 1979. p 227-242.
19. Al-Maghazachi AA, Abdulaziz ZA, Al-Allaf GA. Complement levels in Iraq: a preliminary report. Ann Coll Med Mosul 1979;10:77-83.
20. Freer DE, Statland BE, Johnson M, Felton H. Reference values for selected enzyme activities and protein concentrations is serum and plasma derived from cord-blood specimens. Clin Chem 1979;25:565-569.
21. Fleetwood MK, Maier BA, Lewis SH. Normal range for the third component of complement by solid-phase immunofluorescence. Clin Chem 1981;27:503-504.
22. Jollif CR, Cost KM, Stivrins PC, et al. Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry. Clin Chem 1982;28:126-128.
23. Behr W, Schlimok G, Firchau V, Paul HA. Determination of reference intervals for 10 serum proteins measured by rate nephelometry, taking into consideration different sample groups and different distribution functions. J Clin Chem Clin Biochem 1985;23:157-166.
24. Lockitch G, McCallum C, Halstead C, Pendray M. Reference intervals for eight plasma proteins in preterm and term newborns by laser nephelometry. Clin Chem 1986;32:2106.
25. Hesseling PB, Cooper RC, Girdle-Brown B. Serum immunoglobulin and complement values in onyalai. S Afr Med J 1986:203-205.
26. Sandvei R, Matre R. Serum concentrations of immunoglobulins and complement components in women using an intra-uterine contraceptive device (IUCD). Acta Obstet Gynecol Scand 1987;66:297-299.
27. Lockitch G, Halstead AC, Quigley G, MacCallum C. Age- and sex-specific pediatric reference intervals: study design and methods illustrated by measurement of serum proteins with the Behring LN nephelometer. Clin Chem 1988;34:1618-1621.
28. Muscari A, Bozzoli C, Gerratana C, et al. Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 1988;74:179-186.
29. Meek SC, Hodge DD, Musich JR. Autoimmunity in infertile patients with endometriosis. Am J Obstet Gynecol 1988;158:1365-1373.
30. Thorlacius S, Mollnes TE, Garred P, et al. Plasma exchange in myasthenia gravis: change in serum complement and immunoglobulins. Acta Neurol Scand 1988;78:221-227.
31. Makinde VA, Senaldi G, Jawad ASM, Berry H, Vergani D. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway. Ann Rheum Dis 1989;48:302-306.
32. Spivak B, Radwan M, Elimelech D, Baruch Y, Avidan G, Tyano S. A study of the complement system in psychiatric patients. Biol Psychol 1989;26:640-642.
33. Clady CW, Forristal J, Strife CF, West CD. Serum terminal complement component levels in hypocomplementemic glomerulonephritides. Clin Immunol Immunopathol 1989;50:307-320.
34. Zach TL, Hostetter MK. Biochemical abnormalities of the third component of complement in neonates. Pediatr Res 1989;26:116-120.
35. Meliconi R, Senaldi G, Sturani C, et al. Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity. Clin Immunol Immunopathol 1990;57:64-73.
36. Muscari A, Bozzoli C, Puddi GM, et al. Correlation between serum lipids and complement components in adults without demonstrated atherosclerotic disease. Atherosclerosis 1990;81:111-118.
37. Saito T, Kuwahara A, Schimoda K, et al. Enhanced immunoglobulin levels correlate with infectious complications after surgery in esophageal cancer. J Surg Oncol 1991;46:3-8.
38. Taylor PV, Maloney MD, Campbell JM, et al. Autorectivity in women with endometriosis. Br J Obstet Gynecol 1991;98:680-684.
39. Endersen IM, Relling GB, Tonder O, Myking O, Walther BT, Ursin H. Brief uncontrollable stress and psychological parameters influence human plasma concentrations of IgM and complement component C3. Behav Med 1991-2;17:167-176.
40. Jiang X, Chen F. The effect of lipid peroxidase dismutase on systemic lupus erythematosus: a preliminary study. Clin Immunol Immunopathol 1992;63:39-44.
41. Lin RY, Caveliere LF, Lorenzana FG, Go EF, Altman KA. Pattern of C3, iC3b, and C3d in patients hospitalized for acute asthma. Ann Allergy 1992;68:324-330.
42. Milis L, Timmermens V, Morris CA, Pussell BA, Charlesworth JA. The value of complement measurements in the assessment of lupus activity. Aust N Z J Med 1992;22:338-344.
43. Ota H, Maki M, Shidara Y, et al. Effects of danazol at the immunologic level in patients with adenomyosis, with special reference to autoantibodies: a multi-center cooperative study. Am J Obstet Gynecol 1992;167:481-486.
44. Maillet F, Fremeaux-Bacchi V, Uhring-Lambert B, Kazatchkine MD. Assessment of complement activation in clinical samples. J Immunol Methods 1992;156:171-178.
45. Sarria A, Moreno L, Fleta J, et al. Immunoglobulins, complement components and lymphocyte subsets are related to plasma lipoproteins in healthy children. Atherosclerosis 1992;93:157-159.
46. Mohamed AO, Nilsson UR, Omar MIA, Ronquist G. Lack of evidence for altered complement and immunoglobulin levels in patients with sickle cell anemia. Scand J Clin Lab Invest 1992;52:313-316.
47. Tietz NW, Shuey DF, Wekstein DR. Laboratory values in fit aging individuals-sexagenarians through centenarians. Clin Chem 1992;38:1167-1185.
48. Boyd NAM, Bradwell AR, Thompson RA. Quantitation of vitronectine in serum: evaluation of its usefulness in routine clinical practice. J Clin Pathol 1993;46:1042-1045.
49. Lin RY, Astiz ME, Saxon JC, Saha DC, Rackow EC. Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin Immunol Immunopathol 1993;69:136-142.
50. Hogasen K, Michaelsen T, Mellbye OJ, Bjune G. Low prevalence of complement deficiencies among patients with meningococcal disease in Norway. Scand J Immunol 1993;37:487-489.
51. Tamaro G, Morena C, Uxa F, Candusso M, Trappan A, de Vonderweid U. Serum immunoglobulin and complement levels in prematures with parenteral feeding-preliminary results. Allergy Immunol 1993;1:19-21.
52. Drossou V, Kanakoudi F, Diamanti E, et al. Concentrations of main serum opsonins in early infancy. Arch Dis Child 1995;72:F172-F175.
53. Oyeyinka GO, Aiyedun BA, Erasmus RT, Adewoye HO, Adetoro OO, Adedoyin MA. Complement and immunoglobulin levels in Ilorin Nigeris, and environ. Afr J Med Sci 1995;24:9-16.
54. Bohr J, Tysk C, Yang P, Danielsson D, Jarnerot G. Autoantibodies and immunoglobulins in collagenous colitis. Gut 1996;39:73-76.
55. Kosmas EN, Zorpidou D, Vassilareas V, Roussou T, Michaelides S. Decreased C4 complement component serum levels correlate with the degree of emphysema in patients with chronic bronchitis. Chest 1997;112:341-347.
56. Ekanem EE, Umotong AB, Raykundalia C, Catty D. Serum C-reactive protein and C3 complement protein levels in severely malnourished Nigerian children with and without bacterial infections. Acta Pediatr 1997;86:1317-1320.
57. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2004;18:1-8.
58. Dati F, Schumann G, Thomas L, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for the interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). Eur J Clin Chem Biochem 1996;34:517-520.
59. Itoh Y, Ichihara K, Kanno T, et al. Serum protein standardization project in Japan: evaluation of an IFCC reference material (RPPHS/CRM470) and establishment of reference intervals. J Clin Lab Anal 1997;11:39-44.
60. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for immunoglobulins A, G and M: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1998;12:363-370.
61. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute phase proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999;13:280-286.
62. National Committee for Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory: approved guideline. NCCLS document C28-A. Villanova, PA: NCCLS; 1995.
63. Whicher JW. Minutes of the International Federation of Clinical Chemistry meeting of the Committee on Plasma Proteins, Scientific Division, August 20, 1997. Basel, Switzerland, and October 8, Viareggio, Italy, 1997.